Core Viewpoint - Cancer immunotherapy has transformed cancer treatment, but many patients do not respond. Activating innate immunity presents a promising method to enhance treatment efficacy, yet the specific signal kinases involved remain largely unknown [3]. Group 1: Research Findings - A recent study published in Nature Cancer identified CDK10 as a key driver of immune evasion in cancer cells, which suppresses antitumor immunity by limiting the production of immunostimulatory nucleic acids [3][4]. - The research utilized in vivo CRISPR screening to establish CDK10 as a critical inhibitory factor in tumor immune surveillance [4]. - CDK10 reduces the accumulation of double-stranded RNA and R-loops by phosphorylating DNMT1 and RAP80, thereby dampening the activation of innate immune pathways mediated by MDA5 and cGAS [4]. Group 2: Clinical Implications - The study confirmed that lower expression levels of CDK10 in tumors correlate with better responses to immunotherapy in cancer patients [5]. - These findings position CDK10 as a significant regulatory factor in tumor immunity and a potential therapeutic target [6]. Group 3: Related Commentary - A commentary published alongside the study in Nature Cancer highlighted that the activation of cytoplasmic nucleic acid sensors in tumor cells is a crucial early step in initiating antitumor immunity, although the mechanisms controlling their activity are not fully understood [6].

Core Viewpoint - The research highlights the role of dendritic cells (DC) in regulating the balance between innate and adaptive immunity in lymph nodes, which is crucial for optimal host defense [2][4]. Group 1: Research Findings - Dendritic cells drive the rapid and polarized recruitment of innate effector cells to lymph nodes [4]. - This innate cell infiltration aids in controlling pathogens but limits the adaptive immune response [4]. - Dendritic cells and monocytes clear neutrophils to restore tissue structure and adaptive immune function [4]. - Dendritic cells act as a regulator, balancing the innate and adaptive immune functions in lymph nodes [4]. Group 2: Mechanisms and Processes - Following infection or vaccination, lymph node structures undergo rapid remodeling, with neutrophils and monocytes being recruited from inflammatory blood vessels [3]. - Dendritic cells facilitate this process by expressing inflammatory chemokines and integrin ligands [3]. - After the threat of infection is resolved, dendritic cells and recruited monocytes phagocytize neutrophils, thereby restoring the tissue architecture and creating conditions for the activation of downstream adaptive immune cells [3].